Treatment of inflamed hypertrophic scars using intralesional 5-FU

Authors
Citation
Re. Fitzpatrick, Treatment of inflamed hypertrophic scars using intralesional 5-FU, DERM SURG, 25(3), 1999, pp. 224-232
Citations number
44
Categorie Soggetti
Dermatology
Journal title
DERMATOLOGIC SURGERY
ISSN journal
10760512 → ACNP
Volume
25
Issue
3
Year of publication
1999
Pages
224 - 232
Database
ISI
SICI code
1076-0512(199903)25:3<224:TOIHSU>2.0.ZU;2-C
Abstract
BACKGROUND. Hypertrophic scars and keloids may complicate wound healing sec ondary to trauma or surgery. A variety of treatment regimens have been used with a range of success. OBJECTIVE. The purpose of this paper is to report the use of 5-fluorouracil (5-FU) intralesionally in treatment of inflamed hypertrophic scars, both a s an individual agent as well as in conjunction with low-dose intralesional corticosteroids plus pulsed dye laser therapy. METHODS. The author's 9-year experience in the use of this agent in treatin g hypertrophic scars is summarized, and case reports are used to demonstrat e its efficacy at 50 mg/cc as well as mixed with Kenalog (1 mg/cc) plus con comitant use of the pulsed dye laser. RESULTS. Frequent initial injections (once to thrice weekly) were found to be more efficacious with decreasing frequency (weekly to monthly) during a period of stabilization and resolution of the scars. The combination of 5-F U and Kenalog appeared to be more effective and less painful. The addition of the pulsed dye laser treatments simultaneous with injection therapy was found to be most effective. CONCLUSION. The use of 5-FU intralesionally for treatment of hypertrophic s cars appears to be both effective and safe. Further study is warranted.